Skip to main content
. 2023 Sep 4;10:1244308. doi: 10.3389/fmed.2023.1244308

Table 2.

Staging, treatment, and causes of death for 24 Retinoblastoma patients who died in our series.

Characteristics (total 24 patients) Number (%)
Stage of the worst eye (IIRC)a A,B,C 1 (4%)
D 6 (25%)
E 15 (63%)
Extraocular 2 (8%)
Stage of the worst eye (TNM) T1 0 (0%)
T2 7 (29%)
T3 15 (63%)
T4 2 (8%)
Treatment modalities Primary enucleation 13 (59%)
Primary enucleation (refused)c 4 (17%)
Secondary enucleation 5 (21%)
Neoadjuvent systemic chemotherapy 14 (60%)
EBRTe 8 (33%)
High-risk features (for 18 enucleated eyes) No 4 (17%)
Optic nerve (post laminar) 6 (25%)
Choroid (massive) 7 (29%)
Anterior chamber/ ciliary body 2 (8%)
Cause of death Metastasisb 21 (88%)
Second malignancyd 3 (12%)
Site of metastasis (21 patients) CNS 11 (52%)
Bone marrow 7 (33%)
Multi organ metastasis 3 (14%)
Median time between diagnosis and death 34 months
Median time between metastasis and death 6 months
a

IIRC, International Intraocular Retinoblastoma Classification.

b

One had metastatic pineoblastoma.

c

The primary treatment plan for these 4 patients was enucleation but parents refused decision and came back later on with extraocular disease.

d

Three patients had second malignancy (1 osteosarcoma in the thigh, 1 osteosarcoma in the orbit, and 1 liposarcoma in the back).

e

EBRT, External beam radiation therapy.